SCHEMBL16639781

SCHEMBL16639781

Cc1nc2c(cc1C(=O)NCc1ccc(S(=O)(=O)N3CCOCC3)cc1)c(C)nn2C

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.56
LMNA P02545 1/20 0.54
POLB P06746 3/20 0.54
MAPT P10636 2/20 0.54
MEN1 O00255 2/20 0.54
KMT2A Q03164 2/20 0.54
ALDH1A1 P00352 2/20 0.54
FGB P02675 1/20 0.54
THRB P10828 1/20 0.54
PABPC1 P11940 1/20 0.54
PPARG P37231 1/20 0.54
NCOA2 Q15596 1/20 0.54
NCOA1 Q15788 1/20 0.54
NCOA3 Q9Y6Q9 1/20 0.54
NAMPT P43490 4/20 0.52
SMN1; SMN2 Q16637 2/20 0.52
ALOX15 P16050 1/20 0.52
HSD17B10 Q99714 1/20 0.52
HTT P42858 1/20 0.51
NPSR1 Q6W5P4 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16644189 0.85 TP53 (0.53) TP53LMNAPOLBMAPTMEN1
SCHEMBL16644186 0.82 TP53 (0.51) TP53LMNAPOLBMAPTMEN1
SCHEMBL16644241 0.80 TP53 (0.58) TP53LMNAPOLBMAPTMEN1
SCHEMBL16644185 0.79 KMT2A (0.57) TP53LMNAPOLBMAPTMEN1
SCHEMBL15246331 0.79 LMNA (0.64) TP53LMNAPOLBMAPTMEN1
SCHEMBL16644188 0.77 MAPT (0.56) TP53LMNAPOLBMAPTALDH1A1
SCHEMBL16639773 0.77 ALDH1A1 (0.62) TP53LMNAPOLBMAPTMEN1
SCHEMBL16639792 0.76 ALDH1A1 (0.61) TP53LMNAPOLBMAPTMEN1
SCHEMBL16644184 0.75 HPGD (0.64) TP53LMNAPOLBMAPTMEN1
SCHEMBL16644239 0.75 POLB (0.56) TP53LMNAPOLBMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10696692-B2 Amido-benzyl sulfone and sulfoxide derivates Valo Health, LLC 2020-06-30 US disclosed
US-20150104384-A1 AMIDO-BENZYL SULFONE AND SULFOXIDE DERIVATIVES VALO HEALTH, INC. 2015-04-16 US disclosed
US-20150104384-A1 AMIDO-BENZYL SULFONE AND SULFOXIDE DERIVATIVES VALO HEALTH, INC. 2015-04-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10696692-B2 Amido-benzyl sulfone and sulfoxide derivates STS, SQOR, SULT1E1 TP53 1915/4885LMNA 3203/4885POLB 4094/4885
US-20150104384-A1 AMIDO-BENZYL SULFONE AND SULFOXIDE DERIVATIVES STS, SULT1E1, CBS TP53 2268/4885LMNA 3476/4885POLB 4160/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.